Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Equity (2016 - 2025)

Agios Pharmaceuticals' Return on Equity history spans 13 years, with the latest figure at 0.33% for Q4 2025.

  • For Q4 2025, Return on Equity fell 76.0% year-over-year to 0.33%; the TTM value through Dec 2025 reached 0.33%, down 76.0%, while the annual FY2025 figure was 0.3%, 87.0% down from the prior year.
  • Return on Equity reached 0.33% in Q4 2025 per AGIO's latest filing, down from 0.3% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.46% in Q4 2021 to a low of 0.52% in Q2 2024.
  • Average Return on Equity over 5 years is 0.23%, with a median of 0.0% recorded in 2022.
  • Peak YoY movement for Return on Equity: skyrocketed 186bps in 2021, then crashed -143bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 1.46% in 2021, then tumbled by -100bps to 0.0% in 2022, then plummeted by -11596bps to 0.42% in 2023, then soared by 201bps to 0.42% in 2024, then crashed by -179bps to 0.33% in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Return on Equity are 0.33% (Q4 2025), 0.3% (Q3 2025), and 0.46% (Q2 2025).